Okonogi K, Noji Y, Kondo M, Imada A, Yokota T
Central Research Division, Takeda Chemical Industries, Ltd., Osaka, Japan.
J Antimicrob Chemother. 1989 Nov;24(5):637-45. doi: 10.1093/jac/24.5.637.
Staphylococcus aureus strains specifically resistant to cephamycin antibiotics have been found among recent clinical isolates. These strains formed penicillin-binding protein (PBP) 2' and became phenotypically resistant to methicillin after induction with cefoxitin. Other cephamycin-type antibiotics also induced methicillin-resistance, whereas non-cephamycin-type cephalosporins such as cefmenoxime and ceftizoxime did not do so. The clones that constitutively synthesized PBP 2' arose from the cephamycin-resistant strains at a frequency of 10(-5). They were indistinguishable from clinically isolated methicillin-resistant S. aureus (MRSA). Cephamycin-resistant S. aureus may be a source for emerging MRSA.
近期临床分离株中发现了对头孢霉素抗生素具有特异性抗性的金黄色葡萄球菌菌株。这些菌株形成了青霉素结合蛋白(PBP)2',在用头孢西丁诱导后对甲氧西林产生表型抗性。其他头孢霉素类抗生素也可诱导甲氧西林耐药,而头孢孟多和头孢唑肟等非头孢霉素类头孢菌素则不会。组成型合成PBP 2'的克隆以10^(-5)的频率从头孢霉素抗性菌株中产生。它们与临床分离的耐甲氧西林金黄色葡萄球菌(MRSA)无法区分。耐头孢霉素金黄色葡萄球菌可能是新兴MRSA的一个来源。